University Hospital of Ioannina COVID-19 (Coronavirus Disease 2019) Registry
Launched by UNIVERSITY HOSPITAL, IOANNINA · Sep 7, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The University Hospital of Ioannina is conducting a clinical trial to study COVID-19, which is the disease caused by the coronavirus. This trial involves gathering and analyzing patient information from their medical records to understand how COVID-19 affects people over time. Researchers will track various health details about patients on specific days during their hospital stay and continue to follow them for three months after they leave the hospital. This helps to learn more about the long-term effects of COVID-19, including any ongoing health issues, often referred to as "long COVID."
To participate in this trial, individuals must have tested positive for the coronavirus and been hospitalized due to COVID-19 at the University Hospital of Ioannina. There are no specific exclusions, meaning most patients who meet these criteria are eligible to join. Participants can expect to provide information about their health and receive follow-up care to monitor their recovery. This study aims to improve our understanding of COVID-19 and enhance care for patients affected by the virus.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • PCR positive for SARS-CoV-2
- • hospitalization for COVID-19 disease in the Infectious Diseases Unit of University Hospital of Ioannina, greece
- Exclusion Criteria:
- • none
About University Hospital, Ioannina
The University Hospital of Ioannina is a leading clinical research institution in Greece, dedicated to advancing medical knowledge and patient care through rigorous scientific inquiry. As a prominent academic medical center, it offers a multidisciplinary approach to clinical trials, fostering collaboration among healthcare professionals, researchers, and patients. The hospital is equipped with state-of-the-art facilities and adheres to the highest ethical standards, ensuring the safety and well-being of participants. With a focus on innovative therapies and treatment modalities, the University Hospital of Ioannina is committed to contributing to the global body of medical research and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ioánnina, Epirus, Greece
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials